Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis
- PMID: 7522742
- DOI: 10.1038/ng0794-362
Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis
Abstract
Although first generation recombinant adenoviruses, deleted of sequences spanning E1a and E1b, have been useful for in vivo applications of gene therapy, expression of the recombinant gene has been transient and often associated with the development of inflammation. We show that with first generation adenovirus-mediated gene transfer to the mouse lung, viral proteins are expressed leading to destructive cellular immune responses and repopulation of the lung with nontransgene containing cells. Second generation E1 deleted viruses further crippled by a temperature sensitive mutation in the E2a gene were associated with substantially longer recombinant gene expression and less inflammation. Stable expression of human CF transmembrane conductance regulator has been achieved in lungs of CF mice instilled with a second generation virus.
Similar articles
-
Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.Hum Gene Ther. 1994 Oct;5(10):1217-29. doi: 10.1089/hum.1994.5.10-1217. Hum Gene Ther. 1994. PMID: 7849095
-
Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice.Hum Gene Ther. 1995 Apr;6(4):457-67. doi: 10.1089/hum.1995.6.4-457. Hum Gene Ther. 1995. PMID: 7612702
-
Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study.Hum Gene Ther. 1995 Jul;6(7):839-51. doi: 10.1089/hum.1995.6.7-839. Hum Gene Ther. 1995. PMID: 7578403
-
Gene therapy for cystic fibrosis.Curr Opin Mol Ther. 1999 Aug;1(4):510-6. Curr Opin Mol Ther. 1999. PMID: 11713767 Review.
-
Gene therapy for the respiratory manifestations of cystic fibrosis.Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 2):S75-87. doi: 10.1164/ajrccm/151.3_Pt_2.S75. Am J Respir Crit Care Med. 1995. PMID: 7533609 Review.
Cited by
-
Cell and gene therapy for genetic diseases: inherited disorders affecting the lung and those mimicking sudden infant death syndrome.Hum Gene Ther. 2012 Jun;23(6):548-56. doi: 10.1089/hum.2012.087. Hum Gene Ther. 2012. PMID: 22642257 Free PMC article. Review.
-
Dicationic amphiphiles bearing an amino acid head group with a long-chain hydrophobic tail for in vitro gene delivery applications.RSC Adv. 2022 Nov 21;12(51):33264-33275. doi: 10.1039/d2ra05959b. eCollection 2022 Nov 15. RSC Adv. 2022. PMID: 36425189 Free PMC article.
-
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8829-34. doi: 10.1073/pnas.95.15.8829. Proc Natl Acad Sci U S A. 1998. PMID: 9671764 Free PMC article.
-
Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administration.J Virol. 1998 Sep;72(9):7542-50. doi: 10.1128/JVI.72.9.7542-7550.1998. J Virol. 1998. PMID: 9696851 Free PMC article.
-
Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted.J Virol. 1996 Oct;70(10):7030-8. doi: 10.1128/JVI.70.10.7030-7038.1996. J Virol. 1996. PMID: 8794347 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical